GGGordana Guzijan

Gordana Guzijan

*This is an algorithmically generated author record based on publicly available information.

Gordana Guzijan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anti‐Erythrocyte Antibody Formation in Individuals With and Without Known Sensitisation Pathways Reflecting Indications for Extended Immunohaematology Screening

    by Milanka Milosavić, Marko Lilić, Gordana Guzijan, Dušan Vučetić

    Background: Blood transfusion therapies are of vital importance for many patient groups. They can lead to various complications, with the production of anti‐erythrocyte antibodies (RBC Ab) being of particular importance. To ascertain which group of participants requires greater protection against RBC Abs, we conducted a study on the antibody incidence in part of Bosnia and Herzegovina—Republika Srpska. Methods: We investigated the yearly incidence of the identified RBC Abs from 2016 until the end of 2022. The identification of RBC Abs was performed using the gel method on various platforms with commercial immunohaematological panels. For statistical analysis, Python 3.12 was used. The groups were formed based on the likely form of the RBC Ab development. Results: In 1106 participants, a total of 1297 antibodies were detected. All groups of patients showed significance that corresponded to the statistical hypothesis set beforehand, which indicated the influence of additional undefined parameters. In the third group, containing participants with no known history of an immunisation pathway, a significant result was observed for anti‐K ( p = 1.344 × 10^‐6), which was completely unexpected. Conclusion: All study groups indicated that it would be advantageous to implement the additional analyses to their routine testing. Further research is needed to identify and prepare prevention strategies for all patient groups from this study.

  • Open Access

    Rare occurrence of RHD null alleles with Del expression among serologically D-negative blood donors

    by Marko Lilić, Gordana Guzijan, Snežana Jovanović-Srzentić

    Background/Aim: An investigation into the diversity of serologically D-negative blood donors in the Republic of Srpska entity of Bosnia and Herzegovina forms the basis of this research. The primary purpose of the study was the examination of RHD variants over a period of five years. Methods: A comprehensive depiction of the RHD distribution in D-negative blood donors is achieved through a combination of serological observations and DNA testing (PCR-SSP with fluorometric signal detection), involving 74,149 blood donors. The adsorption/elution method was used to confirm the Del phenotype. Results: A small fraction (0.31 %) of the serologically D-negative blood donors was found to contain eight different RHD alleles. The Del phenotype of the RHD*01N.03 and RHD*01EL.44 alleles was highlighted, challenging the common perception that these alleles are associated exclusively with a D-negative expression. Conclusion: The importance of molecular methods in analysing and understanding Del variants, which typically elude conventional serological assays , is underscored by the findings. A group of donors seemingly having the RHD*01 allele but who lacked D antigen expression was encountered, hinting at the potential presence of still unidentified, possibly geographically restricted, RHD variants or alterations in other genes responsible for the expression of Rh proteins in the erythrocyte membrane.

  • Open Access

    Hepcidin as a biomarker of neonatal infections

    by Jelica Predojevic-Samardzic, Dragana Malcic-Zanic, Zelimir Eric, Gordana Guzijan, Sergej Samardzic

    Introduction/Objective. Nonspecific clinical signs of neonatal infection dictate routinely determination of C-reactive protein (CRP) and procalcitonin levels in order to confirm the diagnosis. As hepcidin is an acute phase reactant, the aim of our study was to analyze its significance in diagnosis of neonatal infections. Methods. The prospective study included 71 term neonates, 37 with signs of infection in the absence of other pathological conditions and 34 healthy neonates. After standard bacteriological examination, at the time of diagnosis and after six days of antibiotic therapy, complete blood count, serum CRP, procalcitonin, and hepcidin were determined. Results. There was no difference in serum hepcidin levels between the control (55.17 ? 21.22 ng/ml) and the infection group (59.72 ? 59.7 ng/ml) on the first day. Hepcidin values in neonates with infection up to 72 hours were significantly lower (30.2 ng/ml, IQ: 25.9?39.9 ng/ml) than in older neonates (82.2 ng/ml, IQ: 39.7?128.1 ng/ml). In neonates up to 72 hours, after six days of antibiotics, the hepcidin values show a significant increase (36.68 ng/ml, IQ; 31.23?50.3 ng/ml). High hepcidin values (128.05 ng/ml, IQ: 60.95?201 ng/ml) were recorded in neonates with CRP over 100 mg/l. Conclusion. Our results shows that the determination of serum hepcidin as a marker of neonatal infection is not relevant in neonates up to 72 hours of life. After six days of antibiotic therapy, the neonates of this group reacted with an increase in hepcidin, while the parallel determined values of CRP and procalcitonin showed a significant decrease.